CeSPIACE: A broad-spectrum peptide inhibitor against variable SARS-CoV-2 spikes
Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...
Hosted on MSN1mon
In silico docking of clinically approved drugs against the SARS-CoV-2 receptor-binding domain
In this study in silico docking models were employed to investigate the molecular interactions between the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein, derived from the ...